Global Migraine Drugs Market Insights, Forecast to 2028

Global Migraine Drugs Market Insights, Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Migraine Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Migraine Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Sumatriptan
1.2.3 Zolmitriptan
1.2.4 Rizatriptan
1.2.5 Others Drug
1.3 Market by Application
1.3.1 Global Migraine Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Household Use
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Migraine Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Migraine Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Migraine Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Migraine Drugs Sales by Region
2.4.1 Global Migraine Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Migraine Drugs by Region (2023-2028)
2.5 Global Migraine Drugs Revenue by Region
2.5.1 Global Migraine Drugs Revenue by Region (2017-2022)
2.5.2 Global Migraine Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Migraine Drugs Sales by Manufacturers
3.1.1 Global Top Migraine Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Migraine Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Migraine Drugs in 2021
3.2 Global Migraine Drugs Revenue by Manufacturers
3.2.1 Global Migraine Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Migraine Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Migraine Drugs Revenue in 2021
3.3 Global Migraine Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Migraine Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Migraine Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Migraine Drugs Sales by Type
4.1.1 Global Migraine Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Migraine Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Migraine Drugs Sales Market Share by Type (2017-2028)
4.2 Global Migraine Drugs Revenue by Type
4.2.1 Global Migraine Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Migraine Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Migraine Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Migraine Drugs Price by Type
4.3.1 Global Migraine Drugs Price by Type (2017-2022)
4.3.2 Global Migraine Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Migraine Drugs Sales by Application
5.1.1 Global Migraine Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Migraine Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Migraine Drugs Sales Market Share by Application (2017-2028)
5.2 Global Migraine Drugs Revenue by Application
5.2.1 Global Migraine Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Migraine Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Migraine Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Migraine Drugs Price by Application
5.3.1 Global Migraine Drugs Price by Application (2017-2022)
5.3.2 Global Migraine Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Migraine Drugs Market Size by Type
6.1.1 North America Migraine Drugs Sales by Type (2017-2028)
6.1.2 North America Migraine Drugs Revenue by Type (2017-2028)
6.2 North America Migraine Drugs Market Size by Application
6.2.1 North America Migraine Drugs Sales by Application (2017-2028)
6.2.2 North America Migraine Drugs Revenue by Application (2017-2028)
6.3 North America Migraine Drugs Market Size by Country
6.3.1 North America Migraine Drugs Sales by Country (2017-2028)
6.3.2 North America Migraine Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Migraine Drugs Market Size by Type
7.1.1 Europe Migraine Drugs Sales by Type (2017-2028)
7.1.2 Europe Migraine Drugs Revenue by Type (2017-2028)
7.2 Europe Migraine Drugs Market Size by Application
7.2.1 Europe Migraine Drugs Sales by Application (2017-2028)
7.2.2 Europe Migraine Drugs Revenue by Application (2017-2028)
7.3 Europe Migraine Drugs Market Size by Country
7.3.1 Europe Migraine Drugs Sales by Country (2017-2028)
7.3.2 Europe Migraine Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Migraine Drugs Market Size by Type
8.1.1 Asia Pacific Migraine Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Migraine Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Migraine Drugs Market Size by Application
8.2.1 Asia Pacific Migraine Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Migraine Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Migraine Drugs Market Size by Region
8.3.1 Asia Pacific Migraine Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Migraine Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Migraine Drugs Market Size by Type
9.1.1 Latin America Migraine Drugs Sales by Type (2017-2028)
9.1.2 Latin America Migraine Drugs Revenue by Type (2017-2028)
9.2 Latin America Migraine Drugs Market Size by Application
9.2.1 Latin America Migraine Drugs Sales by Application (2017-2028)
9.2.2 Latin America Migraine Drugs Revenue by Application (2017-2028)
9.3 Latin America Migraine Drugs Market Size by Country
9.3.1 Latin America Migraine Drugs Sales by Country (2017-2028)
9.3.2 Latin America Migraine Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Migraine Drugs Market Size by Type
10.1.1 Middle East and Africa Migraine Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Migraine Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Migraine Drugs Market Size by Application
10.2.1 Middle East and Africa Migraine Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Migraine Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Migraine Drugs Market Size by Country
10.3.1 Middle East and Africa Migraine Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Migraine Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Overview
11.1.3 Allergan Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Allergan Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Allergan Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Overview
11.2.3 Merck Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Merck Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Recent Developments
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Overview
11.3.3 Pfizer Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Pfizer Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Pfizer Recent Developments
11.4 Teva
11.4.1 Teva Corporation Information
11.4.2 Teva Overview
11.4.3 Teva Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Teva Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Teva Recent Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Overview
11.5.3 Pfizer Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Pfizer Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer Recent Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Corporation Information
11.6.2 Johnson & Johnson Overview
11.6.3 Johnson & Johnson Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Johnson & Johnson Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Johnson & Johnson Recent Developments
11.7 Endo International
11.7.1 Endo International Corporation Information
11.7.2 Endo International Overview
11.7.3 Endo International Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Endo International Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Endo International Recent Developments
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Corporation Information
11.8.2 GlaxoSmithKline Overview
11.8.3 GlaxoSmithKline Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 GlaxoSmithKline Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 GlaxoSmithKline Recent Developments
11.9 Impax
11.9.1 Impax Corporation Information
11.9.2 Impax Overview
11.9.3 Impax Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Impax Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Impax Recent Developments
11.10 Abbott
11.10.1 Abbott Corporation Information
11.10.2 Abbott Overview
11.10.3 Abbott Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Abbott Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Abbott Recent Developments
11.11 Bayer
11.11.1 Bayer Corporation Information
11.11.2 Bayer Overview
11.11.3 Bayer Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Bayer Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Bayer Recent Developments
11.12 Eli Lilly
11.12.1 Eli Lilly Corporation Information
11.12.2 Eli Lilly Overview
11.12.3 Eli Lilly Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Eli Lilly Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Eli Lilly Recent Developments
11.13 Ethypharm
11.13.1 Ethypharm Corporation Information
11.13.2 Ethypharm Overview
11.13.3 Ethypharm Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Ethypharm Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Ethypharm Recent Developments
11.14 Kowa Pharmaceuticals America
11.14.1 Kowa Pharmaceuticals America Corporation Information
11.14.2 Kowa Pharmaceuticals America Overview
11.14.3 Kowa Pharmaceuticals America Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Kowa Pharmaceuticals America Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Kowa Pharmaceuticals America Recent Developments
11.15 Winston Pharmaceuticals
11.15.1 Winston Pharmaceuticals Corporation Information
11.15.2 Winston Pharmaceuticals Overview
11.15.3 Winston Pharmaceuticals Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Winston Pharmaceuticals Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Winston Pharmaceuticals Recent Developments
11.16 AstraZeneca
11.16.1 AstraZeneca Corporation Information
11.16.2 AstraZeneca Overview
11.16.3 AstraZeneca Migraine Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 AstraZeneca Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 AstraZeneca Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Migraine Drugs Industry Chain Analysis
12.2 Migraine Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Migraine Drugs Production Mode & Process
12.4 Migraine Drugs Sales and Marketing
12.4.1 Migraine Drugs Sales Channels
12.4.2 Migraine Drugs Distributors
12.5 Migraine Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Migraine Drugs Industry Trends
13.2 Migraine Drugs Market Drivers
13.3 Migraine Drugs Market Challenges
13.4 Migraine Drugs Market Restraints
14 Key Findings in The Global Migraine Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Migraine Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Sumatriptan
Table 3. Major Manufacturers of Zolmitriptan
Table 4. Major Manufacturers of Rizatriptan
Table 5. Major Manufacturers of Others Drug
Table 6. Global Migraine Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Migraine Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Migraine Drugs Sales by Region (2017-2022) & (K Pcs)
Table 9. Global Migraine Drugs Sales Market Share by Region (2017-2022)
Table 10. Global Migraine Drugs Sales by Region (2023-2028) & (K Pcs)
Table 11. Global Migraine Drugs Sales Market Share by Region (2023-2028)
Table 12. Global Migraine Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Migraine Drugs Revenue Market Share by Region (2017-2022)
Table 14. Global Migraine Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Migraine Drugs Revenue Market Share by Region (2023-2028)
Table 16. Global Migraine Drugs Sales by Manufacturers (2017-2022) & (K Pcs)
Table 17. Global Migraine Drugs Sales Share by Manufacturers (2017-2022)
Table 18. Global Migraine Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Migraine Drugs Revenue Share by Manufacturers (2017-2022)
Table 20. Migraine Drugs Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 21. Global Migraine Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Migraine Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Migraine Drugs as of 2021)
Table 23. Migraine Drugs Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Migraine Drugs Product Offered
Table 25. Date of Manufacturers Enter into Migraine Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Migraine Drugs Sales by Type (2017-2022) & (K Pcs)
Table 28. Global Migraine Drugs Sales by Type (2023-2028) & (K Pcs)
Table 29. Global Migraine Drugs Sales Share by Type (2017-2022)
Table 30. Global Migraine Drugs Sales Share by Type (2023-2028)
Table 31. Global Migraine Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Migraine Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Migraine Drugs Revenue Share by Type (2017-2022)
Table 34. Global Migraine Drugs Revenue Share by Type (2023-2028)
Table 35. Migraine Drugs Price by Type (2017-2022) & (USD/Pcs)
Table 36. Global Migraine Drugs Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 37. Global Migraine Drugs Sales by Application (2017-2022) & (K Pcs)
Table 38. Global Migraine Drugs Sales by Application (2023-2028) & (K Pcs)
Table 39. Global Migraine Drugs Sales Share by Application (2017-2022)
Table 40. Global Migraine Drugs Sales Share by Application (2023-2028)
Table 41. Global Migraine Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Migraine Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Migraine Drugs Revenue Share by Application (2017-2022)
Table 44. Global Migraine Drugs Revenue Share by Application (2023-2028)
Table 45. Migraine Drugs Price by Application (2017-2022) & (USD/Pcs)
Table 46. Global Migraine Drugs Price Forecast by Application (2023-2028) & (USD/Pcs)
Table 47. North America Migraine Drugs Sales by Type (2017-2022) & (K Pcs)
Table 48. North America Migraine Drugs Sales by Type (2023-2028) & (K Pcs)
Table 49. North America Migraine Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Migraine Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Migraine Drugs Sales by Application (2017-2022) & (K Pcs)
Table 52. North America Migraine Drugs Sales by Application (2023-2028) & (K Pcs)
Table 53. North America Migraine Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Migraine Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Migraine Drugs Sales by Country (2017-2022) & (K Pcs)
Table 56. North America Migraine Drugs Sales by Country (2023-2028) & (K Pcs)
Table 57. North America Migraine Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Migraine Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Migraine Drugs Sales by Type (2017-2022) & (K Pcs)
Table 60. Europe Migraine Drugs Sales by Type (2023-2028) & (K Pcs)
Table 61. Europe Migraine Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Migraine Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Migraine Drugs Sales by Application (2017-2022) & (K Pcs)
Table 64. Europe Migraine Drugs Sales by Application (2023-2028) & (K Pcs)
Table 65. Europe Migraine Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Migraine Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Migraine Drugs Sales by Country (2017-2022) & (K Pcs)
Table 68. Europe Migraine Drugs Sales by Country (2023-2028) & (K Pcs)
Table 69. Europe Migraine Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Migraine Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Migraine Drugs Sales by Type (2017-2022) & (K Pcs)
Table 72. Asia Pacific Migraine Drugs Sales by Type (2023-2028) & (K Pcs)
Table 73. Asia Pacific Migraine Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Migraine Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Migraine Drugs Sales by Application (2017-2022) & (K Pcs)
Table 76. Asia Pacific Migraine Drugs Sales by Application (2023-2028) & (K Pcs)
Table 77. Asia Pacific Migraine Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Migraine Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Migraine Drugs Sales by Region (2017-2022) & (K Pcs)
Table 80. Asia Pacific Migraine Drugs Sales by Region (2023-2028) & (K Pcs)
Table 81. Asia Pacific Migraine Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Migraine Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Migraine Drugs Sales by Type (2017-2022) & (K Pcs)
Table 84. Latin America Migraine Drugs Sales by Type (2023-2028) & (K Pcs)
Table 85. Latin America Migraine Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Migraine Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Migraine Drugs Sales by Application (2017-2022) & (K Pcs)
Table 88. Latin America Migraine Drugs Sales by Application (2023-2028) & (K Pcs)
Table 89. Latin America Migraine Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Migraine Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Migraine Drugs Sales by Country (2017-2022) & (K Pcs)
Table 92. Latin America Migraine Drugs Sales by Country (2023-2028) & (K Pcs)
Table 93. Latin America Migraine Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Migraine Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Migraine Drugs Sales by Type (2017-2022) & (K Pcs)
Table 96. Middle East and Africa Migraine Drugs Sales by Type (2023-2028) & (K Pcs)
Table 97. Middle East and Africa Migraine Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Migraine Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Migraine Drugs Sales by Application (2017-2022) & (K Pcs)
Table 100. Middle East and Africa Migraine Drugs Sales by Application (2023-2028) & (K Pcs)
Table 101. Middle East and Africa Migraine Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Migraine Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Migraine Drugs Sales by Country (2017-2022) & (K Pcs)
Table 104. Middle East and Africa Migraine Drugs Sales by Country (2023-2028) & (K Pcs)
Table 105. Middle East and Africa Migraine Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Migraine Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 107. Allergan Corporation Information
Table 108. Allergan Description and Major Businesses
Table 109. Allergan Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 110. Allergan Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Allergan Recent Developments
Table 112. Merck Corporation Information
Table 113. Merck Description and Major Businesses
Table 114. Merck Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 115. Merck Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Merck Recent Developments
Table 117. Pfizer Corporation Information
Table 118. Pfizer Description and Major Businesses
Table 119. Pfizer Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 120. Pfizer Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Pfizer Recent Developments
Table 122. Teva Corporation Information
Table 123. Teva Description and Major Businesses
Table 124. Teva Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 125. Teva Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Teva Recent Developments
Table 127. Pfizer Corporation Information
Table 128. Pfizer Description and Major Businesses
Table 129. Pfizer Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 130. Pfizer Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Pfizer Recent Developments
Table 132. Johnson & Johnson Corporation Information
Table 133. Johnson & Johnson Description and Major Businesses
Table 134. Johnson & Johnson Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 135. Johnson & Johnson Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Johnson & Johnson Recent Developments
Table 137. Endo International Corporation Information
Table 138. Endo International Description and Major Businesses
Table 139. Endo International Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 140. Endo International Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Endo International Recent Developments
Table 142. GlaxoSmithKline Corporation Information
Table 143. GlaxoSmithKline Description and Major Businesses
Table 144. GlaxoSmithKline Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 145. GlaxoSmithKline Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. GlaxoSmithKline Recent Developments
Table 147. Impax Corporation Information
Table 148. Impax Description and Major Businesses
Table 149. Impax Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 150. Impax Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Impax Recent Developments
Table 152. Abbott Corporation Information
Table 153. Abbott Description and Major Businesses
Table 154. Abbott Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 155. Abbott Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Abbott Recent Developments
Table 157. Bayer Corporation Information
Table 158. Bayer Description and Major Businesses
Table 159. Bayer Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 160. Bayer Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Bayer Recent Developments
Table 162. Eli Lilly Corporation Information
Table 163. Eli Lilly Description and Major Businesses
Table 164. Eli Lilly Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 165. Eli Lilly Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Eli Lilly Recent Developments
Table 167. Ethypharm Corporation Information
Table 168. Ethypharm Description and Major Businesses
Table 169. Ethypharm Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 170. Ethypharm Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Ethypharm Recent Developments
Table 172. Kowa Pharmaceuticals America Corporation Information
Table 173. Kowa Pharmaceuticals America Description and Major Businesses
Table 174. Kowa Pharmaceuticals America Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 175. Kowa Pharmaceuticals America Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Kowa Pharmaceuticals America Recent Developments
Table 177. Winston Pharmaceuticals Corporation Information
Table 178. Winston Pharmaceuticals Description and Major Businesses
Table 179. Winston Pharmaceuticals Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 180. Winston Pharmaceuticals Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Winston Pharmaceuticals Recent Developments
Table 182. AstraZeneca Corporation Information
Table 183. AstraZeneca Description and Major Businesses
Table 184. AstraZeneca Migraine Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 185. AstraZeneca Migraine Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. AstraZeneca Recent Developments
Table 187. Key Raw Materials Lists
Table 188. Raw Materials Key Suppliers Lists
Table 189. Migraine Drugs Distributors List
Table 190. Migraine Drugs Customers List
Table 191. Migraine Drugs Market Trends
Table 192. Migraine Drugs Market Drivers
Table 193. Migraine Drugs Market Challenges
Table 194. Migraine Drugs Market Restraints
Table 195. Research Programs/Design for This Report
Table 196. Key Data Information from Secondary Sources
Table 197. Key Data Information from Primary Sources
List of Figures
Figure 1. Migraine Drugs Product Picture
Figure 3. Global Migraine Drugs Market Share by Type in 2021 & 2028
Figure 3. Sumatriptan Product Picture
Figure 4. Zolmitriptan Product Picture
Figure 5. Rizatriptan Product Picture
Figure 6. Others Drug Product Picture
Figure 7. Global Migraine Drugs Market Share by Application in 2021 & 2028
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Household Use
Figure 11. Others
Figure 12. Migraine Drugs Report Years Considered
Figure 13. Global Migraine Drugs Sales 2017-2028 (K Pcs)
Figure 14. Global Migraine Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Migraine Drugs Revenue 2017-2028 (US$ Million)
Figure 16. Global Migraine Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global Migraine Drugs Sales Market Share by Region (2017-2022)
Figure 18. Global Migraine Drugs Sales Market Share by Region (2023-2028)
Figure 19. North America Migraine Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 20. North America Migraine Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe Migraine Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 22. Europe Migraine Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific Migraine Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 24. Asia-Pacific Migraine Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America Migraine Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 26. Latin America Migraine Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa Migraine Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 28. Middle East & Africa Migraine Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The Migraine Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of Migraine Drugs in the World: Market Share by Migraine Drugs Revenue in 2021
Figure 31. Global Migraine Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global Migraine Drugs Sales Market Share by Type (2017-2028)
Figure 33. Global Migraine Drugs Revenue Market Share by Type (2017-2028)
Figure 34. Global Migraine Drugs Sales Market Share by Application (2017-2028)
Figure 35. Global Migraine Drugs Revenue Market Share by Application (2017-2028)
Figure 36. North America Migraine Drugs Sales Market Share by Type (2017-2028)
Figure 37. North America Migraine Drugs R

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Narcolepsy Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 80

According to our LPI (LP Information) latest study, the global Narcolepsy Drug market size was valued at US$ 2715.1 million in 2023. With growing demand in downstream market, the Narcolepsy Drug is forecast to a readjusted size of US$ 5598.9 million by 2030 with a CAGR of 10.9% during review period. The research report highlights the growth potential of the global Narcolepsy Drug market. Narcolepsy Drug are expected to show stable growth in the future market. However, product differentia......

Global Epilepsy Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 121

Market Overview of Global Epilepsy Drugs market: According to our latest research, the global Epilepsy Drugs market looks promising in the next 5 years. As of 2022, the global Epilepsy Drugs market was estimated at USD 4815.92 million, and it's anticipated to reach USD 6053.85 million in 2028, with a CAGR of 3.89% during the forecast years. Anti-epileptic drugs can eliminate or reduce seizures in two ways. One is to affect central neurons to prevent or reduce their pathologic......

Global Neuromyelitis Optica Drug Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 107

According to our LPI (LP Information) latest study, the global Neuromyelitis Optica Drug market size was valued at US$ 46 million in 2023. With growing demand in downstream market, the Neuromyelitis Optica Drug is forecast to a readjusted size of US$ 57 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential of the global Neuromyelitis Optica Drug market. Neuromyelitis Optica Drug are expected to show stable growth in the future marke......

Migraine Drugs - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 118

The global Migraine Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Migraine Drugs in various end use industries. The expanding demands from the Hospitals, Clinics, Household Use and Others, are propelling Migraine Drugs market. Sumatriptan, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in......

Global Neuromyelitis Optica Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 19-Dec-2023        Price: US 3380 Onwards        Pages: 121

Market Overview of Global Neuromyelitis Optica Drug market: According to our latest research, the global Neuromyelitis Optica Drug market looks promising in the next 5 years. As of 2022, the global Neuromyelitis Optica Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the glo......

Global Narcolepsy Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 126

Market Overview of Global Narcolepsy Drug market: According to our latest research, the global Narcolepsy Drug market looks promising in the next 5 years. As of 2022, the global Narcolepsy Drug market was estimated at USD 2915.59 million, and it's anticipated to reach USD 5983.81 million in 2028, with a CAGR of 12.73% during the forecast years. Narcolepsy is a neurological disorder characterized by the brain's inability to control sleep/wakefulness cycles. This......

Global Edaravone Market Research Report 2023

Published: 05-Dec-2023        Price: US 2900 Onwards        Pages: 88

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Edaravone market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Mitsubishi Tanabe Pharma - Simcere - Taj Pharmaceuticals Ltd. - Sun Pharmaceutical Industries Ltd. - Unichem Laboratories Ltd - UCB India Ltd - Piram......

Global Ethoxyquin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Ethoxyquin market: According to our latest research, the global Ethoxyquin market looks promising in the next 5 years. As of 2022, the global Ethoxyquin market was estimated at USD 216.07 million, and it's anticipated to reach USD 303.42 million in 2028, with a CAGR of 5.82% during the forecast years. Ethoxyquin (EQ) is a clear, viscous, light yellow to dark brown liquid, with an unpleasant, mercaptan-like smell, that causes irritation of the skin an......

Global Antipsychotic Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 12-Oct-2023        Price: US 3380 Onwards        Pages: 117

Market Overview of Global Antipsychotic Drugs market: According to our latest research, the global Antipsychotic Drugs market looks promising in the next 5 years. As of 2022, the global Antipsychotic Drugs market was estimated at USD 15363.6 million, and it's anticipated to reach USD 23658.8 million in 2028, with a CAGR of 7.46% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global An......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs